HemoTypeSC Has a CE Mark and is Registered in Ghana, Nigeria, and Kenya

Implementation of HemoTypeSC Sickle Cell Disease Screening in Uganda

Erik Serrao, PhD, of Silver Lake Research Corporation, Azusa, CA, presents the implementation of a sickle cell disease screening program in Uganda using HemoTypeSC. Newborn diagnostic screening is not widely implemented in Africa due to cost and logistical problems with current diagnostic methods; a low-cost, user-friendly test is needed to help address this issue.
VJHemOnc – Video Journal of Hematological Oncology
ASH Conference 2018